The ultimate goal of the Division’s research efforts, which include basic, translational, and clinical research aimed at improving diagnosis and treatment for allergic, immunologic, and rheumatologic disorders. The basic and translational approaches are diverse and include using nanotechnology (atomic force microscopy), next generation sequencing, such as whole exome and transcriptome sequencing, single cell cytometry by time-of-flight (Cy-TOF), as well as many other cellular and molecular approaches. Clinical research involves both therapeutic trials based at Stanford, such as in food allergy desensitization, as well as multi-center investigations to evaluate therapy and the pathogenesis of pediatric rheumatologic diseases.